Study shows metyrapone effective for treating rare Cushing’s Syndrome
The first ever prospective study to test the safety and efficacy of metyrapone in patients with Cushing’s Syndrome in a real-life setting has shown...
Could COVID-19 lead to an increase in antimicrobial resistance?
According to a new study, the use of antibiotics in the treatment of COVID-19 could lead to an increase in antimicrobial resistance (AMR) among...
The Ketamine Conference: A Molecular Masterclass
The Ketamine Conference: A Molecular Masterclass is set to take place today, featuring a host of experts in the delivery of ketamine therapy for...
European Commission reaches agreement on potential COVID-19 vaccine
Today, the European Commission has reached a first agreement with the pharmaceutical company AstraZeneca to purchase a potential vaccine against COVID-19.
Once the vaccine has...
First at-home treatment for spinal muscular atrophy approved by FDA
The first at-home, orally administered treatment for spinal muscular atrophy has been approved by the US Food and Drug Administration (FDA).
The treatment – Evrysdi...
New way to increase antimicrobial sensitivity discovered
Scientists have discovered a new way to make bacteria more sensitive to antibiotics in a bid to tackle the antibiotic resistance crisis.
In a new...
Reducing wound bioburden with antimicrobial dressings
HEQ examines the role of dressings with antimicrobial properties in treating and preventing wound infection.
The increased prevalence of antimicrobial dressings in wound care can...
Reduce esketamine price to manage treatment-resistant depression
Researchers are hoping their new paper will encourage policymakers, insurers, and healthcare leaders to work to reduce the price of esketamine nasal spray to...
Innovative antibiotics to be available for UK patients in world-first scheme
A new scheme that starts this week is aiming to provide innovative antibiotics to NHS patients for the first time in almost 30 years...
Capture the Fracture aims for 25% reduction in osteoporosis fractures
UCB Amgen has today announced a collaboration with the International Osteoporosis Foundation (IOF) to support its Capture the Fracture® programme.
The Capture the Fracture® programme...
Tetra Bio-Pharma: building business on healing cannabinoid medicines
Canada’s Tetra Bio-Pharma is on a path to become a world leader in the development of cannabinoid-derived medicines.
Canada’s Tetra Bio-Pharma is on a path...
Taking biopharmaceutical vaccine candidates from research to clinical trial
The Vaccine Development Department at Statens Serum Institut provides experience and expertise at each stage of the research and development process for biopharmaceutical vaccine...
Could ibogaine offer a revolutionary long-term solution to addiction?
Derived from the iboga plant, ibogaine is a psychoactive compound that could have huge potential as a long-term solution to addiction. ATAI Life Sciences...
New EU approved flu vaccine is designed to protect over 65’s
The European Commission has given regulatory approval for the first adjuvanted quadrivalent influenza vaccine to become available across Europe and is designed to protect...
Senolytic drugs: can this antibiotic treat symptoms of ageing?
Professor Michael P Lisanti of the University of Salford highlights the potential applications of senolytic drugs in treating age-associated conditions.
Professor Michael P Lisanti, Chair...
UK companies to supply drugs for major UK COVID-19 drugs trial
Four drugs have been announced as the first to be involved with a major COVID-19 drugs trial that will be testing their efficacy for...
A 500-day journey prescribing medicinal cannabis in Australia
Donielle Paul BSN, RN follows Dr Ben Jansen along his 500-day journey prescribing medicinal cannabis in Australia.
Dr Ben Jansen’s mission is solid: ‘to do...
WHO: reducing disease inequality with vaccine funding
The World Health Organization has welcomed crucial new funding for vaccines across the globe that it says will help in the fight against COVID-19,...
Could arketamine be a breakthrough therapy for depression?
Clinical trials are being carried out to test the efficacy of arketamine as therapy for depression, with the aim of offering an alternative to...
Coronavirus Global Response campaign aims for affordable vaccine for all
The European Commission’s Coronavirus Global Response campaign has teamed up with Global Citizen to launch the next phase of the campaign that aims to...
